Sinocare Can't Scrap Abbott's Glucose Monitor Ban At UPC
U.S. pharmaceutical company Abbott Laboratories has convinced appellate judges at the Unified Patent Court to uphold its preliminary injunction against Sinocare and its European distributor, marking the latest in Abbott's crackdown...To view the full article, register now.
Already a subscriber? Click here to view full article